The following figure from a 2024 NEJM review illustrates the major sources of lead exposure and the multisystem health effects in both children and adults: [1]
1. History
- Key HPI questions: Onset and duration of symptoms (acute vs. chronic); specific complaints of abdominal pain (colicky, diffuse), constipation, nausea/vomiting, fatigue, headache, irritability, memory/concentration difficulties, muscle/joint aches, weight loss [2-3]
- Symptom characterization: "Lead colic" — severe, intermittent, crampy abdominal pain often with constipation; neuropsychiatric symptoms (mood changes, cognitive slowing, peripheral neuropathy with wrist/foot drop) [2][4]
- Timing/triggers: Occupational exposure timeline, recent home renovation, new hobbies (stained glass, casting bullets, pottery), recent immigration, use of traditional/herbal remedies [1][3]
- Exposure history is critical: Housing age (pre-1978 paint), water source (lead pipes), occupational history (smelting, battery recycling, construction, firing ranges), hobbies, substance use (contaminated opium), imported spices/foods, Ayurvedic/folk remedies, retained bullet fragments [1][3]
- Important negatives: Fever (absent in lead poisoning), diarrhea (constipation is more typical), rash, focal neurologic deficits (unless encephalopathy)
2. Alarm Features
- Encephalopathy: Delirium, seizures, stupor, coma — constitutes a medical emergency, typically at BLL >70 μg/dL [2]
- Acute onset of severe abdominal pain with hemolytic anemia
- New-onset seizures in a child with developmental regression
- Wrist drop or foot drop (motor neuropathy)
- Severe anemia (Hb <7 g/dL) with basophilic stippling
- In children: acute behavioral changes, lethargy, persistent vomiting, ataxia [5-6]
3. Medications
Chelation agents (indicated based on BLL and symptoms): [7-8]
- Succimer (DMSA): Oral chelator; first-line for children with BLL ≥45 μg/dL; dosing: 1050 mg/m²/day × 5 days, then 700 mg/m²/day × 14 days [9]
- CaNa₂EDTA (edetate calcium disodium): IV or IM; 1000 mg/m²/day for 5 days; used alone for BLL 20–70 μg/dL; must be used with dimercaprol (BAL) when BLL >70 μg/dL or symptomatic [8]
- Dimercaprol (BAL): IM only; used in combination with CaNa₂EDTA for severe poisoning/encephalopathy
- D-Penicillamine: Oral; less commonly used, reserved for mild-moderate cases when other agents unavailable
Medication cautions
- CaNa₂EDTA alone may aggravate symptoms at very high BLLs — always combine with BAL when BLL >70 μg/dL [8]
- Ensure adequate urine output before initiating chelation; stop if anuria/oliguria develops [8]
- Dose-reduce CaNa₂EDTA in renal impairment [8]
- Chelation does not reverse neurocognitive damage in children [1][10]
4. Diet
- Calcium-rich foods (dairy, milk, yogurt) are associated with lower BLLs and may decrease intestinal lead absorption [7][11]
- Iron supplementation recommended for iron-deficient children with lead exposure, as iron deficiency enhances lead absorption [1][12]
- Adequate vitamin C intake may be beneficial, though evidence is limited [13]
- Avoid fasting in children — empty stomach increases lead absorption
- Dietary interventions alone have limited utility in reducing BLLs when exposure is low, but remain part of standard counseling [9][14]
5. Review of Systems
- GI: Abdominal pain, constipation, nausea, vomiting, anorexia, metallic taste
- Neuro: Headache, irritability, difficulty concentrating, memory loss, peripheral neuropathy (motor > sensory), tremor, ataxia, seizures [2]
- Heme: Fatigue, pallor (anemia)
- MSK: Myalgias, arthralgias, "lead lines" on gums (Burton's lines — blue-black discoloration at gingival margin)
- Renal: Polyuria, gout (lead nephropathy)
- Reproductive: Infertility, miscarriage, preterm birth [2][9]
- Psych: Behavioral changes, ADHD-like symptoms in children, depression in adults
6. Collateral History and Family History
- Interview family members about the home environment: age of housing, peeling/chipping paint, recent renovations [6][10]
- Occupational history of household members — "take-home" lead on clothing/shoes from parents working in lead industries [6]
- Siblings and household contacts should be screened if one child is affected
- Cultural practices: use of traditional remedies (Ayurvedic, folk medicines), imported cosmetics (kohl/surma), lead-glazed pottery for cooking [1][3]
- Immigration history — prior residence in countries with higher lead exposure [7]
7. Risk Factors
- Age <6 years (mouthing behaviors, higher GI absorption, developing CNS) [1][6]
- Housing built before 1978 (lead-based paint); highest risk if built before 1950 [7]
- Low socioeconomic status [7][15]
- Occupational exposure: Smelting, battery manufacturing/recycling, construction, painting, firing ranges, auto repair [1]
- Iron or calcium deficiency (enhances lead absorption) [1][11]
- Substance use: Contaminated opium, illicit methamphetamine [3][16]
- Retained bullet/shrapnel fragments [1]
- Lead service lines for drinking water [1]
- Proximity to airports (leaded aviation fuel), industrial sites [1]
- Race/ethnicity disparities: Non-Hispanic Black children have higher prevalence of elevated BLLs [7]
8. Differential Diagnosis
- Iron deficiency anemia — microcytic anemia without basophilic stippling; check iron studies
- Acute abdomen (appendicitis, bowel obstruction, renal colic) — lead colic mimics surgical abdomen but lacks peritoneal signs [4][17]
- Porphyria (acute intermittent) — abdominal pain, neuropsychiatric symptoms, elevated urine porphyrins; distinguished by specific porphyrin patterns
- Other heavy metal poisoning (arsenic, mercury, thallium) — check heavy metal panel
- Sideroblastic anemia — ringed sideroblasts on bone marrow biopsy
- Thalassemia — microcytic anemia with target cells; hemoglobin electrophoresis distinguishes [18]
- Hepatitis — elevated LFTs may overlap; lead can cause transaminase elevation [16]
- Encephalitis/meningitis — in children presenting with encephalopathy and seizures
- ADHD/learning disabilities — in children with chronic low-level exposure, may be the only manifestation
9. Past Medical History
- Prior episodes of lead exposure or elevated BLLs
- History of pica (especially in children; rare in adults but reported) [19]
- Iron deficiency anemia
- Developmental delays or learning disabilities in children
- Chronic kidney disease (lead nephropathy may be both cause and consequence)
- Gout (saturnine gout)
- Hypertension [2]
- Pregnancy history — prior miscarriages, preterm births [2][9]
10. Physical Exam
- Vital signs: Hypertension (even at low-level chronic exposure) [1-2]
- General: Pallor, wasting, fatigue
- HEENT: Burton's lines — blue-black line at the gingival margin (classic but not always present)
- Abdomen: Diffuse tenderness without peritoneal signs (lead colic); constipation [4]
- Neuro: Motor neuropathy — wrist drop (radial nerve) or foot drop (peroneal nerve); decreased grip strength; tremor; ataxia; cognitive impairment; in severe cases, papilledema (encephalopathy) [2]
- Skin: Pallor
- Pediatric: Developmental assessment, growth parameters, behavioral observation
11. Lab Studies
- Blood lead level (BLL): The primary diagnostic test; venous sample preferred; capillary screening acceptable but must be confirmed with venous draw [7][20]
- CDC reference value for children: 3.5 μg/dL (updated 2021) [6][20]
- Adults: <5 μg/dL considered normal; 5–10 μg/dL requires follow-up; >10 μg/dL warrants environmental assessment [2]
- CBC with peripheral smear: Microcytic hypochromic anemia; basophilic stippling of RBCs (pathognomonic clue but not always present); reticulocytosis [16][21-22]
- Reticulocyte count: May be elevated (hemolytic component)
- Iron studies: To assess concurrent iron deficiency
- BMP/CMP: Renal function (BUN, creatinine — lead nephropathy); uric acid (saturnine gout)
- Free erythrocyte protoporphyrin (FEP) or zinc protoporphyrin (ZPP): Elevated; useful as screening adjunct but not specific [13]
- Urinalysis: Proteinuria, aminoaciduria (Fanconi-like syndrome in severe cases)
- LFTs: May be mildly elevated
- 24-hour urine lead: Can assess body burden; used in provocative chelation testing
The following figure demonstrates the classic finding of basophilic stippling on peripheral blood smear (Panel A), a key diagnostic clue in lead poisoning: [23]
12. Imaging
- Abdominal X-ray (KUB): Indicated when ingestion of lead-containing foreign bodies is suspected (paint chips, bullets, metallic objects); radio-opaque flecks may be visible in the GI tract. In children with BLL ≥55 μg/dL, ~26% had radiographic evidence of paint chip ingestion [19][24-25]
- Long bone X-rays (children): "Lead lines" — dense metaphyseal bands at the growth plates of long bones; indicate chronic exposure [26]
- CT head: Indicated for encephalopathy; may show subcortical and basal ganglia hyperdensities in severe cases [26]
- Imaging is NOT routinely needed for all lead poisoning cases — reserve for suspected ingestion, encephalopathy, or when BLL source is unclear [27-28]
13. Special Tests
- Provocative chelation test (CaNa₂EDTA mobilization test): Historically used to assess body lead burden; less commonly performed now [8]
- K-shell X-ray fluorescence (XRF): Measures bone lead levels; research tool for assessing cumulative exposure; not widely available clinically [29-30]
- Developmental screening tools: In children — Denver Developmental Screening, Bayley Scales; neurocognitive testing for school-age children with chronic exposure
- Nerve conduction studies/EMG: If peripheral neuropathy suspected (motor > sensory, typically extensor muscles)
14. ECG
- QT prolongation: Cumulative lead exposure is associated with prolonged QTc interval; a 10 μg/g increase in tibia lead associated with ~5 ms increase in QTc [30-31]
- QRS prolongation: Associated with higher bone lead levels [29-30]
- High QRS voltage: Reported in occupationally exposed workers with lead poisoning [32]
- Conduction disturbances: Intraventricular block (younger patients), AV block (older patients) [30]
- Reduced heart rate variability in children [1]
- ECG monitoring is recommended in symptomatic patients and those with occupational exposure at BLL >35 μg/dL; not routinely indicated for low-level exposure [31]
15. Assessment
Severity stratification by BLL: [2][7][20]
- Most symptoms occur at BLL ≥50 μg/dL, but neurodevelopmental effects in children occur at much lower levels with no safe threshold [1][7]
- Chronic low-level exposure is a leading risk factor for cardiovascular mortality in adults [1][33]
- Atypical presentations are common — lead poisoning is frequently misdiagnosed as renal colic, hepatitis, or functional abdominal pain [16-17]
16. Treatment Plan
Initial stabilization (severe/encephalopathy)
- ABCs; seizure management with benzodiazepines
- Establish IV access; ensure adequate urine output before chelation [8]
- Whole bowel irrigation if radiopaque material visible on KUB [19]
Chelation therapy: [7-8]
- BLL ≥45 μg/dL (children) or ≥40 μg/dL symptomatic (adults): Succimer (DMSA) 1050 mg/m²/day × 5 days → 700 mg/m²/day × 14 days; OR CaNa₂EDTA 1000 mg/m²/day IV/IM × 5 days
- BLL ≥70 μg/dL or encephalopathy: Dimercaprol (BAL) 75 mg/m² IM q4h + CaNa₂EDTA 1000 mg/m²/day (start CaNa₂EDTA 4 hours after first BAL dose); 5-day course, then 2–4 day rest before repeating [8]
- Monitor renal function, electrolytes, CBC during chelation
- Expect BLL rebound after chelation due to redistribution from bone stores [8]
Source removal: The single most important intervention — identify and eliminate the exposure source [7]
Supportive care
- Iron supplementation if iron-deficient [12]
- Nutritional counseling: calcium-rich diet, adequate iron and vitamin C [7][11]
- Environmental investigation and lead hazard abatement for housing [7]
17. Disposition
- Admit (inpatient/ICU): BLL ≥70 μg/dL, encephalopathy, seizures, symptomatic patients requiring parenteral chelation, inability to ensure removal from exposure source [2]
- Observation: BLL 45–69 μg/dL with mild symptoms; initiate oral chelation and monitor
- Discharge: Asymptomatic patients with BLL <45 μg/dL after confirmatory testing, with clear plan for source identification and follow-up
- Consult: Toxicology/Poison Control for all chelation decisions; public health department for environmental investigation; pediatric developmental services for children with elevated BLLs [15]
18. Follow Up / Return Precautions
- Repeat BLL: Within 1–4 weeks after chelation (expect rebound); serial monitoring until BLL is consistently declining [8]
- Children with BLL 3.5–9 μg/dL: Rescreen in 1–3 months depending on level and risk factors [20]
- Children with BLL ≥10 μg/dL: Follow-up BLL within 1 month; environmental investigation [15]
- Developmental monitoring: Referral for neurodevelopmental assessment in children with any elevated BLL; effects may be irreversible [6][10]
- Return precautions: Instruct patients/families to return for recurrent abdominal pain, vomiting, lethargy, seizures, behavioral changes, or new neurologic symptoms
- Long-term: Cardiovascular risk monitoring in adults with chronic exposure (hypertension, renal function); lead stored in bone can remobilize during pregnancy, menopause, or hyperthyroidism [1][34]
- Public health reporting: Lead poisoning is a reportable condition; coordinate with local health department for case management and environmental remediation [6]
References
1. Lead Poisoning. — Lanphear B, Navas-Acien A, Bellinger DC. The New England Journal of Medicine. 2024.
2. Committee Opinion No. 533: Lead Screening During Pregnancy and Lactation. — Committee on Obstetric Practice Obstetrics and Gynecology. 2012.
3. A Systematic Review of Clinical and Laboratory Findings of Lead Poisoning: Lessons From Case Reports. — Samarghandian S, Shirazi FM, Saeedi F, et al. Toxicology and Applied Pharmacology. 2021.
4. An Unusual Cause of Recurrent Abdominal Pain. — Jongnarangsin K, Mukherjee S, Bauer MA. The American Journal of Gastroenterology. 1999.
5. Investigation of Lead and Chromium Exposure After Consumption of Contaminated Cinnamon-Containing Applesauce — United States, November 2023–April 2024. — Alyssa N. Troeschel PhD, Melanie C. Buser MPH, Andrea Winquist MD PhD, et al United States Centers for Disease Control and Prevention. 2025.
6. Childhood Lead Poisoning Prevention Training 2023-2024. — Mary Jean Brown, David E. Jacobs, Monica Leonard, et al United States Centers for Disease Control and Prevention. 2024.
7. Screening for Elevated Blood Lead Levels in Children and Pregnant Women: US Preventive Services Task Force Recommendation Statement. — US Preventive Services Task Force, Curry SJ, Krist AH, et al. The Journal of the American Medical Association. 2019.
8. FDA Drug Label. — Updated date: 2025-02-13. Food and Drug Administration.
9. Screening for Elevated Blood Lead Levels in Childhood and Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. — Cantor AG, Hendrickson R, Blazina I, et al. The Journal of the American Medical Association. 2019.
10. Household Interventions for Secondary Prevention of Domestic Lead Exposure in Children. — Nussbaumer-Streit B, Mayr V, Dobrescu AI, et al. The Cochrane Database of Systematic Reviews. 2020.
11. Nutritional Status and Diet as Predictors of Children's Lead Concentrations in Blood and Urine. — Kordas K, Burganowski R, Roy A, et al. Environment International. 2018.
12. Lead Poisoning in Children. — Warniment C, Tsang K, Galazka SS. American Family Physician. 2010.
13. An Overview of Lead Toxicity and Its Therapeutic Strategies. — Rawat PS, Singh S. Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements. 2026.
14. Examining Links Between Diet and Lead Exposure in Young Children: 2009 to 2014 National Health and Nutrition Examination Survey. — Desai G, Anzman-Frasca S, Vernarelli JA, et al. Academic Pediatrics. 2021.
15. Lead Poisoning in Children. — Mayans L. American Family Physician. 2019.
16. Acute Lead Poisoning in Two Users of Illicit Methamphetamine. — Allcott JV, Barnhart RA, Mooney LA. The Journal of the American Medical Association. 1987.
17. Chronic Lead Poisoning Induced Abdominal Pain and Anemia: A Case Report and Review of the Literature. — Yang Y, Li S, Wang H, et al. BMC Gastroenterology. 2020.
18. Anemia in Infants and Children: Evaluation and Treatment. — Raleigh MF, Yano AS, Shaffer NE. American Family Physician. 2024.
19. Lead Poisoning Following Ingestion of Pieces of Lead Roofing Plates: Pica-Like Behavior in an Adult. — Sabouraud S, Testud F, Descotes J, Benevent M, Soglu G. Clinical Toxicology. 2008.
20. Update of the Blood Lead Reference Value - United States, 2021. — Ruckart PZ, Jones RL, Courtney JG, et al. MMWR. Morbidity and Mortality Weekly Report. 2021.
21. Basophilic Stippling in Red Blood Cells in the Bone Marrow: Indication for Lead Poisoning Diagnosis. — Kano N, Fukui S, Kushiro S, et al. The Journal of International Medical Research. 2022.
22. A Case of Lead Intoxication: Clinical and Biochemical Studies. — Miwa S, Ishida Y, Takegawa S, Urata G, Toyoda T. American Journal of Hematology. 1981.
23. Diagnosis from the Blood Smear. — Bain BJ. The New England Journal of Medicine. 2005.
24. Radiological Diagnosis of Inorganic Lead Poisoning. — Rovira M, Calvet X, Ros E, Nogué S, Navarro S. Journal of Clinical Gastroenterology. 1989.
25. Prevalence of Radiographic Evidence of Paint Chip Ingestion Among Children With Moderate to Severe Lead Poisoning, St Louis, Missouri, 1989 Through 1990. — McElvaine MD, DeUngria EG, Matté TD, Copley CG, Binder S. Pediatrics. 1992.
26. Radiological Changes in Lead Poisoning. — Alvarenga Fernandes D, Assunção Jorge M, de Melo Alexandre Fraga A, Reis F. Clinical Toxicology. 2024.
27. Lead Poisoning Due to Ingestion of Lead-Contaminated Opium: A Diagnostic Study on Patients' Imaging Findings. — Zamani N, Hassanian-Moghaddam H, Bahrami-Motlagh H, Ahmadi S, Phillips S. Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements. 2019.
28. Intoxication From an Accidentally Ingested Lead Shot Retained in the Gastrointestinal Tract. — Gustavsson P, Gerhardsson L. Environmental Health Perspectives. 2005.
29. Prospective Cohort Study of Lead Exposure and Electrocardiographic Conduction Disturbances in the Department of Veterans Affairs Normative Aging Study. — Eum KD, Nie LH, Schwartz J, et al. Environmental Health Perspectives. 2011.
30. Electrocardiographic Conduction Disturbances in Association With Low-Level Lead Exposure (The Normative Aging Study). — Cheng Y, Schwartz J, Vokonas PS, et al. The American Journal of Cardiology. 1998.
31. The Analysis of QT Interval and Repolarization Morphology of the Heart in Chronic Exposure to Lead. — Kiełtucki J, Dobrakowski M, Pawlas N, et al. Human & Experimental Toxicology. 2017.
32. ECG Conduction Disturbances and Ryanodine Receptor Expression Levels in Occupational Lead Exposure Workers. — Xie J, Du G, Zhang Y, et al. Occupational and Environmental Medicine. 2019.
33. Lead-Attributable Cardiovascular Disease Burden. — GBD 2023 Lead Collaborators, Stanaway JD, Spearman S, et al. The Journal of the American Medical Association. 2026.
34. Water, Soil, Noise, and Light Pollution: JACC Focus Seminar, Part 2. — Miller MR, Landrigan PJ, Arora M, et al. Journal of the American College of Cardiology. 2024.